Eevia Health Plc Interim Report Q2 - 2023
Significant events during the second quarter of 2023:· Net sales1 grew by 16% from KEUR 1 710 in Q1-23 to KEUR 1 985 in Q2-23. Net sales between Q2-22 and Q2-23 grew by 8% (from KEUR 1 835 in Q2-22 to KEUR 1 935 in Q2-23). · The gross profit in Q2-23 landed at KEUR 1 352, an improvement of 137% from KEUR 989 in Q1-23 and up 216% from KEUR 627 in Q2-22. The gross margin2 was 68% in Q2-23, up from 58% in Q1-23 but in line with 68% in Q2-22. The increase since the previous quarter is due to higher volumes of high-margin products, as well as continued improvements in production and